HomeCompareCELP vs JNJ

CELP vs JNJ: Dividend Comparison 2026

CELP yields 1534.34% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CELP wins by $5.47M in total portfolio value
10 years
CELP
CELP
● Live price
1534.34%
Share price
$0.49
Annual div
$7.49
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.51M
Annual income
$41,615.09
Full CELP calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — CELP vs JNJ

📍 CELP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCELPJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CELP + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CELP pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CELP
Annual income on $10K today (after 15% tax)
$130,419.21/yr
After 10yr DRIP, annual income (after tax)
$35,372.83/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, CELP beats the other by $31,335.43/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CELP + JNJ for your $10,000?

CELP: 50%JNJ: 50%
100% JNJ50/50100% CELP
Portfolio after 10yr
$2.77M
Annual income
$23,182.49/yr
Blended yield
0.84%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CELP
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CELP buys
0
JNJ buys
0
No recent congressional trades found for CELP or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCELPJNJ
Forward yield1534.34%2.14%
Annual dividend / share$7.49$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%28%
Portfolio after 10y$5.51M$30.5K
Annual income after 10y$41,615.09$4,749.88
Total dividends collected$3.79M$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CELP vs JNJ ($10,000, DRIP)

YearCELP PortfolioCELP Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$87,417$76,717.18$10,594$274.49+$76.8KCELP
2$406,920$313,383.17$11,294$360.69+$395.6KCELP
3$1,117,073$681,669.18$12,133$476.91+$1.10MCELP
4$2,069,714$874,445.84$13,156$635.42+$2.06MCELP
5$2,971,685$757,090.68$14,432$854.61+$2.96MCELP
6$3,687,659$507,956.48$16,056$1,162.76+$3.67MCELP
7$4,240,346$294,551.18$18,175$1,604.53+$4.22MCELP
8$4,695,440$158,269.62$21,009$2,252.68+$4.67MCELP
9$5,106,016$81,895.26$24,911$3,229.73+$5.08MCELP
10$5,505,053$41,615.09$30,458$4,749.88+$5.47MCELP

CELP vs JNJ: Complete Analysis 2026

CELPStock

Cypress Environmental Partners, L.P. provides independent inspection, integrity, and support services in North America. The company operates in three segments: Inspection Services, Pipeline & Process Services (PPS), and Environmental Services. The Inspection Services segment offers inspection and integrity services on various infrastructure assets, including midstream pipelines, gathering systems, and distribution systems. This segment also provides various services, such as nondestructive examination, in-line inspection support, pig tracking, survey, data gathering, and supervision of third-party contractors. The PPS segment offers hydrostatic testing, chemical cleaning, water transfer and recycling, pumping, pigging, flushing, filling, dehydration, caliper runs, in-line inspection tool run support, nitrogen purging, and drying services, as well as test documentation and records retention services. The Environmental Services segment owns and operates 9 water treatment facilities with ten environmental protection agency class II injection wells in the Bakken shale region of the Williston Basin in North Dakota. This segment offers treatment, recovery, separation, and disposal of waste byproducts generated during the lifecycle of an oil and natural gas well to protect the environment and drinking water. The company serves owners and operators of pipelines and other infrastructure, public utility or local distribution, pipeline construction, oil and natural gas exploration and production, and trucking companies, as well as third-party purchasers of residual oil. Cypress Environmental Partners GP, LLC operates as the general partner of the company. The company was formerly known as Cypress Energy Partners, L.P. and changed its name to Cypress Environmental Partners, L.P. in March 2020. Cypress Environmental Partners, L.P. was founded in 2003 and is headquartered in Tulsa, Oklahoma.

Full CELP Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this CELP vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CELP vs SCHDCELP vs JEPICELP vs OCELP vs KOCELP vs MAINCELP vs ABBVCELP vs MRKCELP vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.